Largest silicone device trial launched in breast implants market

Posted on
Groupe SEBBIN SAS, one of the foremost leaders in France breast implants market, has apparently announced that it has just brought an inclusion phase to a closure – a phase that includes the clinical study of nearly 1,000 patients depicting breast augmentation or reconstruction. For the record, Groupe SEBBIN has been an established French company for more than three decades, and is reputed for developing, manufacturing, and commercializing high quality implants and myriad other medical solutions for reconstructive surgery.

Leave a Reply

Your email address will not be published. Required fields are marked *